Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2018
Galcanezumab: First Global Approval.
Yvette N Lamb
PubMed ↗
Publisher ↗
No numbers read from the abstract.
17 papers cite it
2018
2019
2020
2021
2022
2023
2024
2025
this paper
trial
cites it
Galcanezumab: First Global Approval. | OpenQuestion